Skip to content
by Legal Desire
13 March 2023

Linklaters advises QIA on its investment in China-based biopharmaceutical company Oricell Therapeutics

Advising firms

Deal team

3 lawyers named
LawyerFirmSeniorityPracticeOffice
Robert Elliot Lead Linklaters Partner private equity Singapore
Robert Jefferies Linklaters Associate Not stated Not stated
Benran Huang Zhao Sheng Law Firm Associate Not stated Not stated

Stated terms

Stated value
USD 45m (US$45m)
What the figure measures
Total transaction value
Client
Qatar Investment AuthorityInvestor
Counterparties
Oricell Therapeutics Company Limited (Other)
RTW Investments (Investor)